As of March 2024 MoonLake Immunotherapeutics has a market cap of $3.15 Billion. This makes MoonLake Immunotherapeutics the world's 3397th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.15 B | -12.75% |
2023 | $3.61 B | 784.47% |
2022 | $0.40 B |
On Mar 28th, 2024 the market cap of MoonLake Immunotherapeutics was reported to be: